[1]
Ashoush, N. 2017. REVIEW ONPHARMACOKINETICS OF EMPAGLIFLOZIN, AN INHIBITOR OF THE SODIUM GLUCOSE CO-TRANSPORTER-2 (SGLT-2). Asian Journal of Pharmaceutical and Clinical Research. 10, 7 (Jul. 2017), 50–56. DOI:https://doi.org/10.22159/ajpcr.2017.v10i7.18067.